DeviceClearance

RNA1C CONTROL FOR NYCOCARD HBA1C— 510(k) K050961

Substantially Equivalent

Bionostics, Inc.

FDA 510(k) clearance K050961 for RNA1C CONTROL FOR NYCOCARD HBA1C, Substantially Equivalent on 2005-05-13. Applicant: Bionostics, Inc..

Clearance details

Applicant
Bionostics, Inc.
Product code
Code JJX
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Devens, MA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code JJX

product code JJX
Other
2
Total
2

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.